Page last updated: 2024-10-17

bupropion and Headache

bupropion has been researched along with Headache in 10 studies

Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.

Headache: The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS.

Research Excerpts

ExcerptRelevanceReference
"We tested the efficacy of bupropion in the treatment of persons with pathological gambling (PG)."9.12Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. ( Allen, J; Argo, T; Arndt, S; Black, DW; Coryell, WH; Forbush, KT; Perry, P; Shaw, MC, 2007)
" Each drug, besides its therapeutic effect, creates the risk of adverse reactions which number and severity is not always accepted by the patient."5.39[Safety of nicotine addiction treatment]. ( Cieślewicz, A; Jabłecka, A; Korzeniowska, K, 2013)
"We tested the efficacy of bupropion in the treatment of persons with pathological gambling (PG)."5.12Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study. ( Allen, J; Argo, T; Arndt, S; Black, DW; Coryell, WH; Forbush, KT; Perry, P; Shaw, MC, 2007)
"Outpatients with moderate to severe major depressive disorder (DSM-IV) received bupropion SR (100-300 mg/day) or sertraline (50-200 mg/day) for 16 weeks."5.08Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients. ( Ascher, JA; Hughes, AR; Johnston, JA; Kavoussi, RJ; Segraves, RT, 1997)
"Bupropion has a comparable safety and efficacy profile with methylphenidate in children and adolescents with ADHD."2.77Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study. ( Akhondzadeh, S; Ashrafi, M; Jafarinia, M; Khajavi, D; Modabbernia, A; Mohammadi, MR; Tabrizi, M; Yadegari, N, 2012)
"For a population with a yearly recurrence rate of 30%, the NNTB is 8 (95% CI 6 to 12)."2.61Second-generation antidepressants for preventing seasonal affective disorder in adults. ( Forneris, CA; Gartlehner, G; Gaynes, BN; Greenblatt, A; Lux, LJ; Morgan, LC; Nussbaumer-Streit, B; Van Noord, MG; Winkler, D; Wipplinger, J, 2019)
"To assess the risk of headache associated with commonly prescribed antidepressant medications and to examine the impact of medication class, pharmacodynamics and dosage on risk of headache."2.58Meta-analysis: Second generation antidepressants and headache. ( Bloch, MH; Olten, B; Telang, S; Walton, C, 2018)
"Bupropion is a cytochrome p450 2D6 inhibitor and care must be taken when coprescribing with drugs cleared by this enzyme and when coprescribing with drugs that lower seizure threshold."2.43Bupropion. ( Wilkes, S, 2006)
"Study data demonstrate that seizure incidence, which is a concern with high-dose IR, is substantially lower with the new SR formulation."2.40Bupropion sustained release: side effect profile. ( Settle, EC, 1998)
" Each drug, besides its therapeutic effect, creates the risk of adverse reactions which number and severity is not always accepted by the patient."1.39[Safety of nicotine addiction treatment]. ( Cieślewicz, A; Jabłecka, A; Korzeniowska, K, 2013)

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (30.00)18.2507
2000's3 (30.00)29.6817
2010's4 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Telang, S1
Walton, C1
Olten, B1
Bloch, MH1
Gartlehner, G1
Nussbaumer-Streit, B1
Gaynes, BN1
Forneris, CA1
Morgan, LC1
Greenblatt, A1
Wipplinger, J1
Lux, LJ1
Van Noord, MG1
Winkler, D1
Korzeniowska, K1
Cieślewicz, A1
Jabłecka, A1
Jafarinia, M1
Mohammadi, MR1
Modabbernia, A1
Ashrafi, M1
Khajavi, D1
Tabrizi, M1
Yadegari, N1
Akhondzadeh, S1
Wilkes, S1
Menza, MA1
Dobkin, RD1
Marin, H1
Black, DW1
Arndt, S1
Coryell, WH1
Argo, T1
Forbush, KT1
Shaw, MC1
Perry, P1
Allen, J1
Kavoussi, RJ1
Segraves, RT1
Hughes, AR1
Ascher, JA1
Johnston, JA1
Pinsker, W1
Settle, EC1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Bupropion Versus Placebo in the Treatment of Pathological Gambling[NCT00055393]80 participants (Actual)Interventional2002-07-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for bupropion and Headache

ArticleYear
Meta-analysis: Second generation antidepressants and headache.
    Journal of affective disorders, 2018, 08-15, Volume: 236

    Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Citalopram; Depression; Double-

2018
Second-generation antidepressants for preventing seasonal affective disorder in adults.
    The Cochrane database of systematic reviews, 2019, 03-18, Volume: 3

    Topics: Adult; Antidepressive Agents, Second-Generation; Bupropion; Diarrhea; Headache; Humans; Incidence; N

2019
Bupropion.
    Drugs of today (Barcelona, Spain : 1998), 2006, Volume: 42, Issue:10

    Topics: Antidepressive Agents, Second-Generation; Bupropion; Dizziness; Headache; Humans; Models, Biological

2006
Bupropion sustained release: side effect profile.
    The Journal of clinical psychiatry, 1998, Volume: 59 Suppl 4

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Bupropion; Delayed-Actio

1998

Trials

4 trials available for bupropion and Headache

ArticleYear
Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
    Human psychopharmacology, 2012, Volume: 27, Issue:4

    Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Bupropion; Child; Dopamine Uptake Inhibit

2012
An open-label trial of aripiprazole augmentation for treatment-resistant generalized anxiety disorder.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2

    Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antipsyc

2007
Bupropion in the treatment of pathological gambling: a randomized, double-blind, placebo-controlled, flexible-dose study.
    Journal of clinical psychopharmacology, 2007, Volume: 27, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Bupropion; Diagnostic and Statistical Manu

2007
Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:12

    Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents; Bupropion; Delayed

1997

Other Studies

2 other studies available for bupropion and Headache

ArticleYear
[Safety of nicotine addiction treatment].
    Przeglad lekarski, 2013, Volume: 70, Issue:10

    Topics: Abdominal Pain; Adult; Alkaloids; Azocines; Benzazepines; Boredom; Bupropion; Female; Headache; Huma

2013
Treatment of headache with bupropion.
    Headache, 1998, Volume: 38, Issue:1

    Topics: Bupropion; Chronic Disease; Dopamine Uptake Inhibitors; Headache; Humans; Recurrence

1998